Literature DB >> 1733685

Anal sphincter imaging in fecal incontinence using endosonography.

M A Cuesta1, S Meijer, E J Derksen, H Boutkan, S G Meuwissen.   

Abstract

Clinical anal examination, manometry (resting and squeeze pressures), and single-fiber electromyography were compared with endosonography of the anal sphincters in 14 patients with fecal incontinence. Technical aspects of the procedure and normal imaging of the puborectal muscle and both sphincters were defined. Defects in both sphincters were seen in nine patients. The defect is visualized as a clear discontinuity in the muscular ring. Compared with the conventional studies, anal endosonography gave significant information in six patients (four male patients after perianal surgery and two women), showing sphincter defects in five patients and integrity of the sphincters in another one. This information obtained by endosonography was important in understanding the type and extension of the lesion and deciding upon the surgical repair. Anal endosonography is an imaging technique of the sphincters that can assess their integrity in fecal incontinence.

Entities:  

Mesh:

Year:  1992        PMID: 1733685     DOI: 10.1007/bf02053340

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  4 in total

Review 1.  Fecal incontinence.

Authors:  M Lamah; D Kumar
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

Review 2.  Anal endosonography in faecal incontinence.

Authors:  C I Bartram; A H Sultan
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

3.  Anal pressure vectography is of no apparent benefit for sphincter evaluation.

Authors:  Y K Yang; S D Wexner
Journal:  Int J Colorectal Dis       Date:  1994-05       Impact factor: 2.571

4.  Laparoscopic rectopexy for complete rectal prolapse. Clinical outcome and anorectal function tests.

Authors:  A C Poen; M de Brauw; R J Felt-Bersma; D de Jong; M A Cuesta
Journal:  Surg Endosc       Date:  1996-09       Impact factor: 4.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.